FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,167.79-0.13%
XLE56.77-0.18%
STOXX50E5,860.32-0.39%
XLF51.810.76%
FTSE10,321.09-0.56%
IXIC24,887.100.20%
RUT2,788.190.04%
GSPC7,173.910.12%
Temp30.1°C
UV1.5
Feels35.3°C
Humidity59%
Wind10.8 km/h
Air QualityAQI 1
Cloud Cover50%
Rain0%
Sunrise06:00 AM
Sunset06:47 PM
Time5:39 PM
GNMSFPNKHealthcare

Genmab A/S

Reports in 10d· 2026-05-07
$281.75
+9.92 (+3.65%)

News

(3)

April 2026

3 weeks ago6-K

GENMAB A/S — 6-K Filing

GNMSFGENMAB A/S

# 🧾 What This Document Is This is a standard regulatory filing, called a 6-K, from the biotech company Genmab. Its sole purpose is to publicly disclose stock transactions made by its top executives. Think of it as a required transparency report so investors know what the company's leaders are doin

Read summaryView on SEC EDGAR
3 weeks ago6-K

GENMAB A/S — 6-K Filing

GNMSFGENMAB A/S

# 🧾 What This Document Is This is a **6-K filing**, which is a report international companies like Genmab (based in Denmark) submit to the U.S. SEC to announce major events. This specific event is a **"Major Shareholder Announcement."** It's a formal notification required by Danish law when an inve

Read summaryView on SEC EDGAR

March 2026

0 months ago6-K

GENMAB A/S — 6-K Filing

GNMSFGENMAB A/S

# 🧾 What This Document Is This is a **6-K form**, which is a current report filed with the SEC by foreign companies (like Danish Genmab) to share important events with U.S. investors. This specific filing is a "Major Shareholder Announcement." It's like a mandatory public notification saying, "Hey,

Read summaryView on SEC EDGAR